US Patent 9452222 Nucleic acids encoding modified relaxin polypeptides
Patent 9452222 was granted and assigned to Ambrx on September, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 10, 2014
0
Date of Patent
September 27, 2016
0
Patent Applicant
Patent Application Number
14152302
0
Patent Inventor Names
Nick Knudsen
0
Ahma Hewet
0
Jason Pinkstaff
0
Kristine De Dios
0
Lorraine Sullivan
0
Vadim Kraynov
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9452222 Nucleic acids encoding modified relaxin polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
